Tekla Life Sciences Investors

$19.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-0.85%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can watch HQL and buy or sell other stocks, options, and ETFs commission-free!

About HQL

Tekla Life Sciences Investors is a non-diversified closed-end healthcare fund, which engages in investing in the life sciences industry. The fund primarily invest in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, and healthcare information technology and services. The company was founded on May 8, 1992 and is headquartered in Boston, MA. The listed name for HQL is Tekla Life Sciences Investors.

CEO
Daniel R. Omstead
Employees
—
Headquarters
Boston, Massachusetts
Founded
1992
Market Cap
477.55M
Price-Earnings Ratio
52.55
Dividend Yield
7.77
Average Volume
100.27K
High Today
$20.12
Low Today
$19.30
Open Price
$19.98
Volume
144.37K
52 Week High
$22.32
52 Week Low
$11.45

You May Also Like

GRID
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure